PRIMECAP Management Reduces Stake in Rhythm Pharmaceuticals [Yahoo! Finance]
Rhythm Pharmaceuticals, Inc. (RYTM)
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rhythmtx.com
Company Research
Source: Yahoo! Finance
PRIMECAP Management Trades Portfolio ), a notable investment firm, has recently adjusted its investment portfolio by reducing its stake in Rhythm Pharmaceuticals Inc ( NASDAQ:RYTM ). This move, executed on December 31, 2023, reflects the firm's ongoing portfolio management strategy and its assessment of RYTM's investment potential. Insight into PRIMECAP Management Trades Portfolio Founded in 1983, PRIMECAP Management Trades Portfolio ) has established itself as an independent investment management company based in Pasadena, CA. The firm is known for managing equity portfolios with a focus on the US market, catering to a select group of institutions and mutual funds. PRIMECAP Management Trades Portfolio )'s investment philosophy is grounded in four key principles: individual decision-making, a commitment to fundamental research, a long-term investment horizon, and a focus on value. The firm employs a multi-counselor investment model, granting each portfolio manager autonomy over a
Show less
Read more
Impact Snapshot
Event Time:
RYTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RYTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RYTM alerts
High impacting Rhythm Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RYTM
News
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $42.00 price target on the stock, down previously from $49.00.MarketBeat
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $42.00 price target on the stock, down previously from $49.00.MarketBeat
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target lowered by analysts at Needham & Company LLC from $50.00 to $46.00. They now have a "buy" rating on the stock.MarketBeat
- Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update [Yahoo! Finance]Yahoo! Finance
- Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business UpdateGlobeNewswire
RYTM
Earnings
- 5/7/24 - Miss
RYTM
Sec Filings
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 4/30/24 - Form SC
- RYTM's page on the SEC website